12-221456-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_016615.5(SLC6A13):c.1606C>T(p.Leu536Phe) variant causes a missense change. The variant allele was found at a frequency of 0.00000205 in 1,461,674 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_016615.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC6A13 | NM_016615.5 | c.1606C>T | p.Leu536Phe | missense_variant | 14/15 | ENST00000343164.9 | NP_057699.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC6A13 | ENST00000343164.9 | c.1606C>T | p.Leu536Phe | missense_variant | 14/15 | 1 | NM_016615.5 | ENSP00000339260.4 | ||
SLC6A13 | ENST00000445055.6 | c.1330C>T | p.Leu444Phe | missense_variant | 12/13 | 2 | ENSP00000407104.2 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.00000797 AC: 2AN: 250938Hom.: 1 AF XY: 0.0000147 AC XY: 2AN XY: 135710
GnomAD4 exome AF: 0.00000205 AC: 3AN: 1461674Hom.: 1 Cov.: 33 AF XY: 0.00000413 AC XY: 3AN XY: 727148
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 01, 2024 | The c.1606C>T (p.L536F) alteration is located in exon 14 (coding exon 13) of the SLC6A13 gene. This alteration results from a C to T substitution at nucleotide position 1606, causing the leucine (L) at amino acid position 536 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at